特定ポリペプチド分析装置の世界市場調査レポート2022年版Global Specific Polypeptide Analyzers Market Research Report 2022 COVID-19のパンデミックにより、Specific Polypeptide Analyzersの世界市場規模は2022年に28億5030万米ドルと推定され、2028年には36億4874万米ドルに再調整されると予測、予測期間2022-2028年のCAGRは4.20%と予... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーCOVID-19のパンデミックにより、Specific Polypeptide Analyzersの世界市場規模は2022年に28億5030万米ドルと推定され、2028年には36億4874万米ドルに再調整されると予測、予測期間2022-2028年のCAGRは4.20%と予測されています。この健康危機による経済変化を十分に考慮すると、2021年の特定ポリペプチド分析器世界市場の84.54%を占める全自動タイプは、2022年から2028年までCAGR4.54%で成長し、2028年までに31億6492万米ドルになると予測されます。一方、病院分野は、この予測期間(2022年〜2028年)を通してCAGR4.44%に変更されています。2021年の北米の特定ポリペプチド分析装置市場規模は9億0254万米ドル、欧州は9億3295万米ドル。2021年の北米の割合は33.81%、欧州は34.96%で、欧州の市場シェアは2028年には34.15%に達し、分析期間(2022-2028年)を通してCAGR3.79%で推移すると予測されます。アジアに関しては、中国とインドが注目すべき市場です。 特定ポリペプチド分析装置の世界的な主要メーカーは、Roche、Siemens Healthineers、Beckman Coulter(Danaher)、Abbott、NIHON KOHDEN、Lifotronic、Boditech、Goldsite Diagnostics、Genrui Biotech、Hipro、Aidian、Rayto、Lituo Biotech、UD-Bioなどである。収益面では、2021年の特定ポリペプチド分析装置の市場シェアは、世界3大企業が71.34%を占めています。 本レポートでは、世界レベル、地域レベル、企業レベルでのSpecific Polypeptide Analyzersの数量と価値に焦点を当てます。グローバルな視点から、過去のデータと将来の見通しを分析することで、Specific Polypeptide Analyzersの全体的な市場規模を表しています。 特定ポリペプチド分析計の世界市場。セグメント分析 この調査レポートは、地域(国)別、企業別、タイプ別、用途別の具体的なセグメントを含んでいます。この調査では、2017年から2028年までの過去および予測期間における売上と収益に関する情報を提供しています。セグメントを理解することは、市場成長を助ける様々な要因の重要性を特定するのに役立ちます。 世界の特定ポリペプチド分析器市場。セグメント分析 この調査レポートは、地域(国)別、メーカー別、タイプ別、用途別の具体的なセグメントを含んでいます。各タイプは、2017年から2028年の予測期間中の生産に関する情報を提供します。アプリケーション別セグメントはまた、2017年から2028年の予測期間中の消費量を提供します。セグメントを理解することは、市場の成長を助けるさまざまな要因の重要性を特定するのに役立ちます。 企業別 シーメンス・ヘルヒネアーズ ベックマン・コールター(ダナハー) エイディアン ボディーテック ロシュ 日本光電工業 アボット アガッペ パラメディカ メリルライフ ライフトロニック ゴールドサイト・ダイアグノスティックス Genrui Biotech ヒプロ リトゥオバイオテック UD-バイオ レイトー アッパー ARIメディカル バイオステック タイプ別セグメント 全自動タイプ セミオートマチックタイプ 用途別セグメント 病院 保健所・診療所 その他 地域別消費量 北アメリカ 米国 カナダ アジア太平洋地域 中国 日本 韓国 インド オーストラリア 東南アジア 欧州 ドイツ フランス 英国 イタリア ロシア 中南米 メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア U.A.E. 目次1 SPECIFIC POLYPEPTIDE ANALYZERS MARKET OVERVIEW 11.1 PRODUCT OVERVIEW AND SCOPE OF SPECIFIC POLYPEPTIDE ANALYZERS 1 1.2 SPECIFIC POLYPEPTIDE ANALYZERS SEGMENT BY TYPE 1 1.2.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES GROWTH RATE COMPARISON BY TYPE (2022-2028) 2 1.2.2 FULL-AUTOMATIC TYPE 3 1.2.3 SEMI-AUTOMATIC TYPE 4 1.3 SPECIFIC POLYPEPTIDE ANALYZERS SEGMENT BY APPLICATION 5 1.3.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES COMPARISON BY APPLICATION (2022-2028) 5 1.3.2 HOSPITAL 7 1.3.3 HEALTH CENTER AND CLINIC 7 1.3.4 OTHERS 8 1.4 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS MARKET SIZE ESTIMATES AND FORECASTS 9 1.4.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS REVENUE 2017-2028 9 1.4.2 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES 2017-2028 10 1.4.3 SPECIFIC POLYPEPTIDE ANALYZERS MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028 11 2 SPECIFIC POLYPEPTIDE ANALYZERS MARKET COMPETITION BY MANUFACTURERS 12 2.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES MARKET SHARE BY MANUFACTURERS (2017-2022) 12 2.2 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022) 15 2.3 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS AVERAGE PRICE BY MANUFACTURERS (2017-2022) 18 2.4 SPECIFIC POLYPEPTIDE ANALYZERS MANUFACTURERS HEADQUARTERS, AREA SERVED AND ESTABLISH DATE 19 2.5 SPECIFIC POLYPEPTIDE ANALYZERS MARKET COMPETITIVE SITUATION AND TRENDS 21 2.5.1 SPECIFIC POLYPEPTIDE ANALYZERS MARKET CONCENTRATION RATE 21 2.5.2 THE GLOBAL 3 AND 5 LARGEST SPECIFIC POLYPEPTIDE ANALYZERS PLAYERS MARKET SHARE BY REVENUE 22 2.5.3 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 23 2.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS 24 3 SPECIFIC POLYPEPTIDE ANALYZERS RETROSPECTIVE MARKET SCENARIO BY REGION 26 3.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022 26 3.2 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022 26 3.3 NORTH AMERICA SPECIFIC POLYPEPTIDE ANALYZERS MARKET FACTS & FIGURES BY COUNTRY 27 3.3.1 NORTH AMERICA SPECIFIC POLYPEPTIDE ANALYZERS SALES BY COUNTRY 27 3.3.2 NORTH AMERICA SPECIFIC POLYPEPTIDE ANALYZERS REVENUE BY COUNTRY 28 3.3.3 UNITED STATES 29 3.3.4 CANADA 29 3.4 EUROPE SPECIFIC POLYPEPTIDE ANALYZERS MARKET FACTS & FIGURES BY COUNTRY 30 3.4.1 EUROPE SPECIFIC POLYPEPTIDE ANALYZERS SALES BY COUNTRY 30 3.4.2 EUROPE SPECIFIC POLYPEPTIDE ANALYZERS REVENUE BY COUNTRY 30 3.4.3 GERMANY 31 3.4.4 FRANCE 32 3.4.5 U.K. 32 3.4.6 ITALY 33 3.4.7 RUSSIA 33 3.5 ASIA PACIFIC SPECIFIC POLYPEPTIDE ANALYZERS MARKET FACTS & FIGURES BY REGION 34 3.5.1 ASIA PACIFIC SPECIFIC POLYPEPTIDE ANALYZERS SALES BY REGION 34 3.5.2 ASIA PACIFIC SPECIFIC POLYPEPTIDE ANALYZERS REVENUE BY REGION 34 3.5.3 CHINA 35 3.5.4 JAPAN 36 3.5.5 SOUTH KOREA 37 3.5.6 INDIA 37 3.5.7 AUSTRALIA 38 3.5.8 SOUTHEAST ASIA 39 3.6 LATIN AMERICA SPECIFIC POLYPEPTIDE ANALYZERS MARKET FACTS & FIGURES BY COUNTRY 39 3.6.1 LATIN AMERICA SPECIFIC POLYPEPTIDE ANALYZERS SALES BY COUNTRY 39 3.6.2 LATIN AMERICA SPECIFIC POLYPEPTIDE ANALYZERS REVENUE BY COUNTRY 40 3.6.3 MEXICO 41 3.6.4 BRAZIL 41 3.6.5 ARGENTINA 42 3.6.6 COLOMBIA 43 3.7 MIDDLE EAST AND AFRICA SPECIFIC POLYPEPTIDE ANALYZERS MARKET FACTS & FIGURES BY COUNTRY 43 3.7.1 MIDDLE EAST AND AFRICA SPECIFIC POLYPEPTIDE ANALYZERS SALES BY COUNTRY 43 3.7.2 MIDDLE EAST AND AFRICA SPECIFIC POLYPEPTIDE ANALYZERS REVENUE BY COUNTRY 44 3.7.3 TURKEY 45 3.7.4 SAUDI ARABIA 45 3.7.5 UAE 46 4 SPECIFIC POLYPEPTIDE ANALYZERS HISTORIC MARKET ANALYSIS BY TYPE 47 4.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES MARKET SHARE BY TYPE (2017-2022) 47 4.2 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS REVENUE MARKET SHARE BY TYPE (2017-2022) 48 4.3 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS PRICE BY TYPE (2017-2022) 49 5 SPECIFIC POLYPEPTIDE ANALYZERS HISTORIC MARKET ANALYSIS BY APPLICATION 50 5.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES MARKET SHARE BY APPLICATION (2017-2022) 50 5.2 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS REVENUE MARKET SHARE BY APPLICATION (2017-2022) 50 5.3 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS PRICE BY APPLICATION (2017-2022) 51 6 KEY COMPANIES PROFILED 52 6.1 SIEMENS HEALTHINEERS 52 6.1.1 SIEMENS HEALTHINEERS CORPORATION INFORMATION 52 6.1.2 SIEMENS HEALTHINEERS DESCRIPTION AND BUSINESS OVERVIEW 52 6.1.3 SIEMENS HEALTHINEERS SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 53 6.1.4 SIEMENS HEALTHINEERS SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 53 6.1.5 SIEMENS HEALTHINEERS RECENT DEVELOPMENTS/UPDATES 57 6.2 BECKMAN COULTER (DANAHER) 58 6.2.1 BECKMAN COULTER (DANAHER) CORPORATION INFORMATION 58 6.2.2 BECKMAN COULTER (DANAHER) DESCRIPTION AND BUSINESS OVERVIEW 58 6.2.3 BECKMAN COULTER (DANAHER) SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 60 6.2.4 BECKMAN COULTER (DANAHER) SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 60 6.2.5 BECKMAN COULTER (DANAHER) RECENT DEVELOPMENTS/UPDATES 62 6.3 AIDIAN 62 6.3.1 AIDIAN CORPORATION INFORMATION 62 6.3.2 AIDIAN DESCRIPTION AND BUSINESS OVERVIEW 63 6.3.3 AIDIAN SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 64 6.3.4 AIDIAN SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 64 6.3.5 AIDIAN RECENT DEVELOPMENTS/UPDATES 66 6.4 BODITECH 68 6.4.1 BODITECH CORPORATION INFORMATION 68 6.4.2 BODITECH DESCRIPTION AND BUSINESS OVERVIEW 68 6.4.3 BODITECH SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 69 6.4.4 BODITECH SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 69 6.4.5 BODITECH RECENT DEVELOPMENTS/UPDATES 71 6.5 ROCHE 71 6.5.1 ROCHE CORPORATION INFORMATION 71 6.5.2 ROCHE DESCRIPTION AND BUSINESS OVERVIEW 72 6.5.3 ROCHE SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 73 6.5.4 ROCHE SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 73 6.5.5 ROCHE RECENT DEVELOPMENTS/UPDATES 74 6.6 NIHON KOHDEN 75 6.6.1 NIHON KOHDEN CORPORATION INFORMATION 75 6.6.2 NIHON KOHDEN DESCRIPTION AND BUSINESS OVERVIEW 76 6.6.3 NIHON KOHDEN SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 77 6.6.4 NIHON KOHDEN SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 77 6.6.5 NIHON KOHDEN RECENT DEVELOPMENTS/UPDATES 78 6.7 ABBOTT 79 6.7.1 ABBOTT CORPORATION INFORMATION 79 6.7.2 ABBOTT DESCRIPTION AND BUSINESS OVERVIEW 80 6.7.3 ABBOTT SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 80 6.7.4 ABBOTT SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 81 6.7.5 ABBOTT RECENT DEVELOPMENTS/UPDATES 85 6.8 AGAPPE 85 6.8.1 AGAPPE CORPORATION INFORMATION 85 6.8.2 AGAPPE DESCRIPTION AND BUSINESS OVERVIEW 86 6.8.3 AGAPPE SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 87 6.8.4 AGAPPE SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 87 6.9 PARAMEDICA 91 6.9.1 PARAMEDICA CORPORATION INFORMATION 91 6.9.2 PARAMEDICA DESCRIPTION AND BUSINESS OVERVIEW 92 6.9.3 PARAMEDICA SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 92 6.9.4 PARAMEDICA SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 93 6.10 MERIL LIFE 94 6.10.1 MERIL LIFE CORPORATION INFORMATION 94 6.10.2 MERIL LIFE DESCRIPTION AND BUSINESS OVERVIEW 95 6.10.3 MERIL LIFE SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 96 6.10.4 MERIL LIFE SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 96 6.10.5 MERIL LIFE RECENT DEVELOPMENTS/UPDATES 97 6.11 LIFOTRONIC 97 6.11.1 LIFOTRONIC CORPORATION INFORMATION 97 6.11.2 LIFOTRONIC DESCRIPTION AND BUSINESS OVERVIEW 98 6.11.3 LIFOTRONIC SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 99 6.11.4 LIFOTRONIC SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 99 6.11.5 LIFOTRONIC RECENT DEVELOPMENTS/UPDATES 100 6.12 GOLDSITE DIAGNOSTICS 101 6.12.1 GOLDSITE DIAGNOSTICS CORPORATION INFORMATION 101 6.12.2 GOLDSITE DIAGNOSTICS DESCRIPTION AND BUSINESS OVERVIEW 101 6.12.3 GOLDSITE DIAGNOSTICS SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 102 6.12.4 GOLDSITE DIAGNOSTICS SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 102 6.13 GENRUI BIOTECH 106 6.13.1 GENRUI BIOTECH CORPORATION INFORMATION 106 6.13.2 GENRUI BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 107 6.13.3 GENRUI BIOTECH SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 108 6.13.4 GENRUI BIOTECH SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 108 6.14 HIPRO 110 6.14.1 HIPRO CORPORATION INFORMATION 110 6.14.2 HIPRO DESCRIPTION AND BUSINESS OVERVIEW 111 6.14.3 HIPRO SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 112 6.14.4 HIPRO SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 112 6.15 LITUO BIOTECH 114 6.15.1 LITUO BIOTECH CORPORATION INFORMATION 114 6.15.2 LITUO BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 114 6.15.3 LITUO BIOTECH SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 115 6.15.4 LITUO BIOTECH SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 116 6.16 UD-BIO 117 6.16.1 UD-BIO CORPORATION INFORMATION 117 6.16.2 UD-BIO DESCRIPTION AND BUSINESS OVERVIEW 118 6.16.3 UD-BIO SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 119 6.16.4 UD-BIO SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 119 6.17 RAYTO 120 6.17.1 RAYTO CORPORATION INFORMATION 120 6.17.2 RAYTO DESCRIPTION AND BUSINESS OVERVIEW 121 6.17.3 RAYTO SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 122 6.17.4 RAYTO SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 122 6.18 UPPER 123 6.18.1 UPPER CORPORATION INFORMATION 123 6.18.2 UPPER DESCRIPTION AND BUSINESS OVERVIEW 124 6.18.3 UPPER SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 124 6.18.4 UPPER SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 125 6.19 ARI MEDICAL 125 6.19.1 ARI MEDICAL CORPORATION INFORMATION 125 6.19.2 ARI MEDICAL DESCRIPTION AND BUSINESS OVERVIEW 126 6.19.3 ARI MEDICAL SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 127 6.19.4 ARI MEDICAL SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 127 6.20 BIOSTEC 130 6.20.1 BIOSTEC CORPORATION INFORMATION 130 6.20.2 BIOSTEC DESCRIPTION AND BUSINESS OVERVIEW 131 6.20.3 BIOSTEC SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 132 6.20.4 BIOSTEC SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 132 7 SPECIFIC POLYPEPTIDE ANALYZERS MANUFACTURING COST ANALYSIS 135 7.1 SPECIFIC POLYPEPTIDE ANALYZERS KEY RAW MATERIALS ANALYSIS 135 7.1.1 KEY RAW MATERIALS 135 7.1.2 KEY SUPPLIERS OF RAW MATERIALS 136 7.2 PROPORTION OF MANUFACTURING COST STRUCTURE 136 7.3 MANUFACTURING PROCESS ANALYSIS OF SPECIFIC POLYPEPTIDE ANALYZERS 137 7.4 SPECIFIC POLYPEPTIDE ANALYZERS INDUSTRIAL CHAIN ANALYSIS 138 8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 139 8.1 MARKETING CHANNEL 139 8.2 SPECIFIC POLYPEPTIDE ANALYZERS DISTRIBUTORS LIST 140 8.3 SPECIFIC POLYPEPTIDE ANALYZERS CUSTOMERS 141 9 SPECIFIC POLYPEPTIDE ANALYZERS MARKET DYNAMICS 143 9.1 SPECIFIC POLYPEPTIDE ANALYZERS INDUSTRY TRENDS 143 9.2 SPECIFIC POLYPEPTIDE ANALYZERS MARKET DRIVERS 143 9.3 SPECIFIC POLYPEPTIDE ANALYZERS MARKET CHALLENGES 144 9.4 SPECIFIC POLYPEPTIDE ANALYZERS MARKET RESTRAINTS 144 10 GLOBAL MARKET FORECAST 145 10.1 SPECIFIC POLYPEPTIDE ANALYZERS MARKET ESTIMATES AND PROJECTIONS BY TYPE 145 10.1.1 GLOBAL FORECASTED SALES OF SPECIFIC POLYPEPTIDE ANALYZERS BY TYPE (2023-2028) 145 10.1.2 GLOBAL FORECASTED REVENUE OF SPECIFIC POLYPEPTIDE ANALYZERS BY TYPE (2023-2028) 145 10.2 SPECIFIC POLYPEPTIDE ANALYZERS MARKET ESTIMATES AND PROJECTIONS BY APPLICATION 146 10.2.1 GLOBAL FORECASTED SALES OF SPECIFIC POLYPEPTIDE ANALYZERS BY APPLICATION (2023-2028) 146 10.2.2 GLOBAL FORECASTED REVENUE OF SPECIFIC POLYPEPTIDE ANALYZERS BY APPLICATION (2023-2028) 147 10.3 SPECIFIC POLYPEPTIDE ANALYZERS MARKET ESTIMATES AND PROJECTIONS BY REGION 147 10.3.1 GLOBAL FORECASTED SALES OF SPECIFIC POLYPEPTIDE ANALYZERS BY REGION (2023-2028) 147 10.3.2 GLOBAL FORECASTED REVENUE OF SPECIFIC POLYPEPTIDE ANALYZERS BY REGION (2023-2028) 148 11 RESEARCH FINDINGS AND CONCLUSION 150 12 METHODOLOGY AND DATA SOURCE 152 12.1 METHODOLOGY/RESEARCH APPROACH 152 12.1.1 RESEARCH PROGRAMS/DESIGN 152 12.1.2 MARKET SIZE ESTIMATION 153 12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION 154 12.2 DATA SOURCE 155 12.2.1 SECONDARY SOURCES 155 12.2.2 PRIMARY SOURCES 156 12.3 AUTHOR LIST 158 12.4 DISCLAIMER 159
SummaryDue to the COVID-19 pandemic, the global Specific Polypeptide Analyzers market size is estimated to be worth US$ 2,850.03 million in 2022 and is forecast to a readjusted size of US$ 3,648.74 million by 2028 with a CAGR of 4.20% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Full-Automatic Type accounting for 84.54% of the Specific Polypeptide Analyzers global market in 2021, is projected to value US$ 3,164.92 million by 2028, growing at a revised 4.54% CAGR from 2022 to 2028. While Hospital segment is altered to a 4.44% CAGR throughout this forecast period (2022-2028). Table of Contents1 SPECIFIC POLYPEPTIDE ANALYZERS MARKET OVERVIEW 11.1 PRODUCT OVERVIEW AND SCOPE OF SPECIFIC POLYPEPTIDE ANALYZERS 1 1.2 SPECIFIC POLYPEPTIDE ANALYZERS SEGMENT BY TYPE 1 1.2.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES GROWTH RATE COMPARISON BY TYPE (2022-2028) 2 1.2.2 FULL-AUTOMATIC TYPE 3 1.2.3 SEMI-AUTOMATIC TYPE 4 1.3 SPECIFIC POLYPEPTIDE ANALYZERS SEGMENT BY APPLICATION 5 1.3.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES COMPARISON BY APPLICATION (2022-2028) 5 1.3.2 HOSPITAL 7 1.3.3 HEALTH CENTER AND CLINIC 7 1.3.4 OTHERS 8 1.4 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS MARKET SIZE ESTIMATES AND FORECASTS 9 1.4.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS REVENUE 2017-2028 9 1.4.2 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES 2017-2028 10 1.4.3 SPECIFIC POLYPEPTIDE ANALYZERS MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028 11 2 SPECIFIC POLYPEPTIDE ANALYZERS MARKET COMPETITION BY MANUFACTURERS 12 2.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES MARKET SHARE BY MANUFACTURERS (2017-2022) 12 2.2 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022) 15 2.3 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS AVERAGE PRICE BY MANUFACTURERS (2017-2022) 18 2.4 SPECIFIC POLYPEPTIDE ANALYZERS MANUFACTURERS HEADQUARTERS, AREA SERVED AND ESTABLISH DATE 19 2.5 SPECIFIC POLYPEPTIDE ANALYZERS MARKET COMPETITIVE SITUATION AND TRENDS 21 2.5.1 SPECIFIC POLYPEPTIDE ANALYZERS MARKET CONCENTRATION RATE 21 2.5.2 THE GLOBAL 3 AND 5 LARGEST SPECIFIC POLYPEPTIDE ANALYZERS PLAYERS MARKET SHARE BY REVENUE 22 2.5.3 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 23 2.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS 24 3 SPECIFIC POLYPEPTIDE ANALYZERS RETROSPECTIVE MARKET SCENARIO BY REGION 26 3.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022 26 3.2 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022 26 3.3 NORTH AMERICA SPECIFIC POLYPEPTIDE ANALYZERS MARKET FACTS & FIGURES BY COUNTRY 27 3.3.1 NORTH AMERICA SPECIFIC POLYPEPTIDE ANALYZERS SALES BY COUNTRY 27 3.3.2 NORTH AMERICA SPECIFIC POLYPEPTIDE ANALYZERS REVENUE BY COUNTRY 28 3.3.3 UNITED STATES 29 3.3.4 CANADA 29 3.4 EUROPE SPECIFIC POLYPEPTIDE ANALYZERS MARKET FACTS & FIGURES BY COUNTRY 30 3.4.1 EUROPE SPECIFIC POLYPEPTIDE ANALYZERS SALES BY COUNTRY 30 3.4.2 EUROPE SPECIFIC POLYPEPTIDE ANALYZERS REVENUE BY COUNTRY 30 3.4.3 GERMANY 31 3.4.4 FRANCE 32 3.4.5 U.K. 32 3.4.6 ITALY 33 3.4.7 RUSSIA 33 3.5 ASIA PACIFIC SPECIFIC POLYPEPTIDE ANALYZERS MARKET FACTS & FIGURES BY REGION 34 3.5.1 ASIA PACIFIC SPECIFIC POLYPEPTIDE ANALYZERS SALES BY REGION 34 3.5.2 ASIA PACIFIC SPECIFIC POLYPEPTIDE ANALYZERS REVENUE BY REGION 34 3.5.3 CHINA 35 3.5.4 JAPAN 36 3.5.5 SOUTH KOREA 37 3.5.6 INDIA 37 3.5.7 AUSTRALIA 38 3.5.8 SOUTHEAST ASIA 39 3.6 LATIN AMERICA SPECIFIC POLYPEPTIDE ANALYZERS MARKET FACTS & FIGURES BY COUNTRY 39 3.6.1 LATIN AMERICA SPECIFIC POLYPEPTIDE ANALYZERS SALES BY COUNTRY 39 3.6.2 LATIN AMERICA SPECIFIC POLYPEPTIDE ANALYZERS REVENUE BY COUNTRY 40 3.6.3 MEXICO 41 3.6.4 BRAZIL 41 3.6.5 ARGENTINA 42 3.6.6 COLOMBIA 43 3.7 MIDDLE EAST AND AFRICA SPECIFIC POLYPEPTIDE ANALYZERS MARKET FACTS & FIGURES BY COUNTRY 43 3.7.1 MIDDLE EAST AND AFRICA SPECIFIC POLYPEPTIDE ANALYZERS SALES BY COUNTRY 43 3.7.2 MIDDLE EAST AND AFRICA SPECIFIC POLYPEPTIDE ANALYZERS REVENUE BY COUNTRY 44 3.7.3 TURKEY 45 3.7.4 SAUDI ARABIA 45 3.7.5 UAE 46 4 SPECIFIC POLYPEPTIDE ANALYZERS HISTORIC MARKET ANALYSIS BY TYPE 47 4.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES MARKET SHARE BY TYPE (2017-2022) 47 4.2 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS REVENUE MARKET SHARE BY TYPE (2017-2022) 48 4.3 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS PRICE BY TYPE (2017-2022) 49 5 SPECIFIC POLYPEPTIDE ANALYZERS HISTORIC MARKET ANALYSIS BY APPLICATION 50 5.1 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS SALES MARKET SHARE BY APPLICATION (2017-2022) 50 5.2 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS REVENUE MARKET SHARE BY APPLICATION (2017-2022) 50 5.3 GLOBAL SPECIFIC POLYPEPTIDE ANALYZERS PRICE BY APPLICATION (2017-2022) 51 6 KEY COMPANIES PROFILED 52 6.1 SIEMENS HEALTHINEERS 52 6.1.1 SIEMENS HEALTHINEERS CORPORATION INFORMATION 52 6.1.2 SIEMENS HEALTHINEERS DESCRIPTION AND BUSINESS OVERVIEW 52 6.1.3 SIEMENS HEALTHINEERS SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 53 6.1.4 SIEMENS HEALTHINEERS SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 53 6.1.5 SIEMENS HEALTHINEERS RECENT DEVELOPMENTS/UPDATES 57 6.2 BECKMAN COULTER (DANAHER) 58 6.2.1 BECKMAN COULTER (DANAHER) CORPORATION INFORMATION 58 6.2.2 BECKMAN COULTER (DANAHER) DESCRIPTION AND BUSINESS OVERVIEW 58 6.2.3 BECKMAN COULTER (DANAHER) SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 60 6.2.4 BECKMAN COULTER (DANAHER) SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 60 6.2.5 BECKMAN COULTER (DANAHER) RECENT DEVELOPMENTS/UPDATES 62 6.3 AIDIAN 62 6.3.1 AIDIAN CORPORATION INFORMATION 62 6.3.2 AIDIAN DESCRIPTION AND BUSINESS OVERVIEW 63 6.3.3 AIDIAN SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 64 6.3.4 AIDIAN SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 64 6.3.5 AIDIAN RECENT DEVELOPMENTS/UPDATES 66 6.4 BODITECH 68 6.4.1 BODITECH CORPORATION INFORMATION 68 6.4.2 BODITECH DESCRIPTION AND BUSINESS OVERVIEW 68 6.4.3 BODITECH SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 69 6.4.4 BODITECH SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 69 6.4.5 BODITECH RECENT DEVELOPMENTS/UPDATES 71 6.5 ROCHE 71 6.5.1 ROCHE CORPORATION INFORMATION 71 6.5.2 ROCHE DESCRIPTION AND BUSINESS OVERVIEW 72 6.5.3 ROCHE SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 73 6.5.4 ROCHE SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 73 6.5.5 ROCHE RECENT DEVELOPMENTS/UPDATES 74 6.6 NIHON KOHDEN 75 6.6.1 NIHON KOHDEN CORPORATION INFORMATION 75 6.6.2 NIHON KOHDEN DESCRIPTION AND BUSINESS OVERVIEW 76 6.6.3 NIHON KOHDEN SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 77 6.6.4 NIHON KOHDEN SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 77 6.6.5 NIHON KOHDEN RECENT DEVELOPMENTS/UPDATES 78 6.7 ABBOTT 79 6.7.1 ABBOTT CORPORATION INFORMATION 79 6.7.2 ABBOTT DESCRIPTION AND BUSINESS OVERVIEW 80 6.7.3 ABBOTT SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 80 6.7.4 ABBOTT SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 81 6.7.5 ABBOTT RECENT DEVELOPMENTS/UPDATES 85 6.8 AGAPPE 85 6.8.1 AGAPPE CORPORATION INFORMATION 85 6.8.2 AGAPPE DESCRIPTION AND BUSINESS OVERVIEW 86 6.8.3 AGAPPE SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 87 6.8.4 AGAPPE SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 87 6.9 PARAMEDICA 91 6.9.1 PARAMEDICA CORPORATION INFORMATION 91 6.9.2 PARAMEDICA DESCRIPTION AND BUSINESS OVERVIEW 92 6.9.3 PARAMEDICA SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 92 6.9.4 PARAMEDICA SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 93 6.10 MERIL LIFE 94 6.10.1 MERIL LIFE CORPORATION INFORMATION 94 6.10.2 MERIL LIFE DESCRIPTION AND BUSINESS OVERVIEW 95 6.10.3 MERIL LIFE SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 96 6.10.4 MERIL LIFE SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 96 6.10.5 MERIL LIFE RECENT DEVELOPMENTS/UPDATES 97 6.11 LIFOTRONIC 97 6.11.1 LIFOTRONIC CORPORATION INFORMATION 97 6.11.2 LIFOTRONIC DESCRIPTION AND BUSINESS OVERVIEW 98 6.11.3 LIFOTRONIC SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 99 6.11.4 LIFOTRONIC SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 99 6.11.5 LIFOTRONIC RECENT DEVELOPMENTS/UPDATES 100 6.12 GOLDSITE DIAGNOSTICS 101 6.12.1 GOLDSITE DIAGNOSTICS CORPORATION INFORMATION 101 6.12.2 GOLDSITE DIAGNOSTICS DESCRIPTION AND BUSINESS OVERVIEW 101 6.12.3 GOLDSITE DIAGNOSTICS SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 102 6.12.4 GOLDSITE DIAGNOSTICS SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 102 6.13 GENRUI BIOTECH 106 6.13.1 GENRUI BIOTECH CORPORATION INFORMATION 106 6.13.2 GENRUI BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 107 6.13.3 GENRUI BIOTECH SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 108 6.13.4 GENRUI BIOTECH SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 108 6.14 HIPRO 110 6.14.1 HIPRO CORPORATION INFORMATION 110 6.14.2 HIPRO DESCRIPTION AND BUSINESS OVERVIEW 111 6.14.3 HIPRO SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 112 6.14.4 HIPRO SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 112 6.15 LITUO BIOTECH 114 6.15.1 LITUO BIOTECH CORPORATION INFORMATION 114 6.15.2 LITUO BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 114 6.15.3 LITUO BIOTECH SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 115 6.15.4 LITUO BIOTECH SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 116 6.16 UD-BIO 117 6.16.1 UD-BIO CORPORATION INFORMATION 117 6.16.2 UD-BIO DESCRIPTION AND BUSINESS OVERVIEW 118 6.16.3 UD-BIO SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 119 6.16.4 UD-BIO SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 119 6.17 RAYTO 120 6.17.1 RAYTO CORPORATION INFORMATION 120 6.17.2 RAYTO DESCRIPTION AND BUSINESS OVERVIEW 121 6.17.3 RAYTO SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 122 6.17.4 RAYTO SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 122 6.18 UPPER 123 6.18.1 UPPER CORPORATION INFORMATION 123 6.18.2 UPPER DESCRIPTION AND BUSINESS OVERVIEW 124 6.18.3 UPPER SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 124 6.18.4 UPPER SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 125 6.19 ARI MEDICAL 125 6.19.1 ARI MEDICAL CORPORATION INFORMATION 125 6.19.2 ARI MEDICAL DESCRIPTION AND BUSINESS OVERVIEW 126 6.19.3 ARI MEDICAL SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 127 6.19.4 ARI MEDICAL SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 127 6.20 BIOSTEC 130 6.20.1 BIOSTEC CORPORATION INFORMATION 130 6.20.2 BIOSTEC DESCRIPTION AND BUSINESS OVERVIEW 131 6.20.3 BIOSTEC SPECIFIC POLYPEPTIDE ANALYZERS SALES, REVENUE AND GROSS MARGIN (2017-2022) 132 6.20.4 BIOSTEC SPECIFIC POLYPEPTIDE ANALYZERS PRODUCT PORTFOLIO 132 7 SPECIFIC POLYPEPTIDE ANALYZERS MANUFACTURING COST ANALYSIS 135 7.1 SPECIFIC POLYPEPTIDE ANALYZERS KEY RAW MATERIALS ANALYSIS 135 7.1.1 KEY RAW MATERIALS 135 7.1.2 KEY SUPPLIERS OF RAW MATERIALS 136 7.2 PROPORTION OF MANUFACTURING COST STRUCTURE 136 7.3 MANUFACTURING PROCESS ANALYSIS OF SPECIFIC POLYPEPTIDE ANALYZERS 137 7.4 SPECIFIC POLYPEPTIDE ANALYZERS INDUSTRIAL CHAIN ANALYSIS 138 8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 139 8.1 MARKETING CHANNEL 139 8.2 SPECIFIC POLYPEPTIDE ANALYZERS DISTRIBUTORS LIST 140 8.3 SPECIFIC POLYPEPTIDE ANALYZERS CUSTOMERS 141 9 SPECIFIC POLYPEPTIDE ANALYZERS MARKET DYNAMICS 143 9.1 SPECIFIC POLYPEPTIDE ANALYZERS INDUSTRY TRENDS 143 9.2 SPECIFIC POLYPEPTIDE ANALYZERS MARKET DRIVERS 143 9.3 SPECIFIC POLYPEPTIDE ANALYZERS MARKET CHALLENGES 144 9.4 SPECIFIC POLYPEPTIDE ANALYZERS MARKET RESTRAINTS 144 10 GLOBAL MARKET FORECAST 145 10.1 SPECIFIC POLYPEPTIDE ANALYZERS MARKET ESTIMATES AND PROJECTIONS BY TYPE 145 10.1.1 GLOBAL FORECASTED SALES OF SPECIFIC POLYPEPTIDE ANALYZERS BY TYPE (2023-2028) 145 10.1.2 GLOBAL FORECASTED REVENUE OF SPECIFIC POLYPEPTIDE ANALYZERS BY TYPE (2023-2028) 145 10.2 SPECIFIC POLYPEPTIDE ANALYZERS MARKET ESTIMATES AND PROJECTIONS BY APPLICATION 146 10.2.1 GLOBAL FORECASTED SALES OF SPECIFIC POLYPEPTIDE ANALYZERS BY APPLICATION (2023-2028) 146 10.2.2 GLOBAL FORECASTED REVENUE OF SPECIFIC POLYPEPTIDE ANALYZERS BY APPLICATION (2023-2028) 147 10.3 SPECIFIC POLYPEPTIDE ANALYZERS MARKET ESTIMATES AND PROJECTIONS BY REGION 147 10.3.1 GLOBAL FORECASTED SALES OF SPECIFIC POLYPEPTIDE ANALYZERS BY REGION (2023-2028) 147 10.3.2 GLOBAL FORECASTED REVENUE OF SPECIFIC POLYPEPTIDE ANALYZERS BY REGION (2023-2028) 148 11 RESEARCH FINDINGS AND CONCLUSION 150 12 METHODOLOGY AND DATA SOURCE 152 12.1 METHODOLOGY/RESEARCH APPROACH 152 12.1.1 RESEARCH PROGRAMS/DESIGN 152 12.1.2 MARKET SIZE ESTIMATION 153 12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION 154 12.2 DATA SOURCE 155 12.2.1 SECONDARY SOURCES 155 12.2.2 PRIMARY SOURCES 156 12.3 AUTHOR LIST 158 12.4 DISCLAIMER 159
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポートQYResearch 社の最新刊レポート本レポートと同じKEY WORD(analyzers market)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/01 10:26 153.05 円 167.01 円 200.08 円 |